• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非精原细胞瘤性睾丸癌(NSGCT)治疗中腹膜后淋巴结清扫术(RPLND)的发展历程。

Evolution of retroperitoneal lymphadenectomy (RPLND) in the management of non-seminomatous testicular cancer (NSGCT).

作者信息

Donohue John P

机构信息

Department of Urology, Indiana University Medical Center, 535 North Barnhill Drive, Ste. 420, Indianapolis, IN 46202, USA.

出版信息

Urol Oncol. 2003 Mar-Apr;21(2):129-32. doi: 10.1016/s1078-1439(02)00212-0.

DOI:10.1016/s1078-1439(02)00212-0
PMID:12856641
Abstract

The metastatic lymphatic drainage of testis cancer to the retroperitoneum was noted clinically about a century ago. Beginning with extraperitoneal approaches, RPLND was attempted. The first cure after RPLND of node positive disease was in 1905 by Cuneo in Paris. Transperitoneal approaches failed due to infection until post World War II experience at Walter Reed Army Hospital. Thoracoabdominal approaches became popular several decades later. But Improved exposure and vascular management strategies led to increased usage of the transabdominal approach once again. The advent of platinum based combination chemotherapy has had a major impact on both the timing of and the technical requirements of RPLND. Owing to our early involvement in this area, we have accumulated the largest database available on this disease. Our experience with over 2500 RPLNDs in the last 3 decades is divided between low stage (I and II) and high stage (III, postchemotherapy) disease. The former has been "down-regulated" to modified templates and prospective nerve sparing techniques to preserve ejaculation. The latter has been "up-regulated" to include a spectrum of surgical needs including hepatic, vascular, gut and mediastinal resections. Despite these extended requirements, outcomes are good (> 80% survival) postchemotherapy. The evolutionary change of RPLND reflects an optimal paradigm of surgical-medical oncologic interaction.

摘要

大约一个世纪前,临床上就已注意到睾丸癌会通过淋巴转移至腹膜后。从腹膜外途径开始,人们尝试进行腹膜后淋巴结清扫术(RPLND)。1905年,巴黎的库尼奥首次通过RPLND治愈了淋巴结阳性疾病。在第二次世界大战前,经腹途径因感染而失败,直到沃尔特·里德陆军医院在二战后的经验出现。几十年后,胸腹联合途径开始流行。但随着暴露和血管管理策略的改进,经腹途径的使用再次增加。铂类联合化疗的出现对RPLND的时机和技术要求都产生了重大影响。由于我们早期就涉足该领域,我们积累了关于这种疾病的最大可用数据库。在过去30年里,我们进行了超过2500例RPLND,经验涵盖低分期(I期和II期)和高分期(III期,化疗后)疾病。对于前者,已采用改良模板和前瞻性保留神经技术以保留射精功能,从而进行了“下调”。对于后者,则进行了“上调”,以满足一系列手术需求,包括肝脏、血管、肠道和纵隔切除术。尽管有这些更高的要求,但化疗后的预后良好(生存率>80%)。RPLND的演变反映了外科 - 肿瘤内科相互作用的最佳模式。

相似文献

1
Evolution of retroperitoneal lymphadenectomy (RPLND) in the management of non-seminomatous testicular cancer (NSGCT).非精原细胞瘤性睾丸癌(NSGCT)治疗中腹膜后淋巴结清扫术(RPLND)的发展历程。
Urol Oncol. 2003 Mar-Apr;21(2):129-32. doi: 10.1016/s1078-1439(02)00212-0.
2
Primary and Postchemotherapy Retroperitoneal Lymphadenectomy for Testicular Cancer.睾丸癌的原发和化疗后腹膜后淋巴结切除术。
Oncol Res Treat. 2018;41(6):370-378. doi: 10.1159/000489508. Epub 2018 May 17.
3
Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection.晚期睾丸生殖细胞肿瘤化疗后腹膜后淋巴结清扫术:根治性或改良模板切除术。
Eur Urol. 2009 Jan;55(1):217-24. doi: 10.1016/j.eururo.2008.09.027. Epub 2008 Sep 24.
4
Utilization of retroperitoneal lymph node dissection for testicular cancer in the United States: Results from the National Cancer Database (1998-2011).美国睾丸癌腹膜后淋巴结清扫术的应用:来自国家癌症数据库的结果(1998 - 2011年)
Urol Oncol. 2016 Nov;34(11):487.e7-487.e11. doi: 10.1016/j.urolonc.2016.05.036. Epub 2016 Jun 29.
5
Laparoscopic retroperitoneal lymphadenectomy for stage I non-seminomatous testicular tumors.腹腔镜下I期非精原细胞瘤性睾丸肿瘤腹膜后淋巴结清扫术
Hepatogastroenterology. 2005 Nov-Dec;52(66):1677-80.
6
Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage II, nonseminomatous germ cell tumor: first 100 patients.化疗后腹腔镜腹膜后淋巴结清扫术治疗低容量 II 期非精原细胞瘤生殖细胞肿瘤:前 100 例患者。
Eur Urol. 2013 Jun;63(6):1013-7. doi: 10.1016/j.eururo.2012.09.036. Epub 2012 Sep 24.
7
Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors.转移性睾丸非精原细胞瘤患者化疗后残留肿块的切除及有限的腹膜后淋巴结清扫术。
Cancer. 1994 Aug 15;74(4):1329-34. doi: 10.1002/1097-0142(19940815)74:4<1329::aid-cncr2820740424>3.0.co;2-l.
8
Midline Extraperitoneal Approach to Retroperitoneal Lymph Node Dissection in Testicular Cancer: Minimizing Surgical Morbidity.中腹部腹膜外入路在睾丸癌腹膜后淋巴结清扫术中的应用:降低手术并发症。
Eur Urol. 2017 Nov;72(5):814-820. doi: 10.1016/j.eururo.2017.02.024. Epub 2017 Mar 18.
9
Retroperitoneal lymph node dissection as adjuvant therapy in the treatment of non-seminomatous testicular cancer.腹膜后淋巴结清扫术作为非精原细胞瘤性睾丸癌治疗的辅助疗法。
Acta Chir Belg. 2003 Nov-Dec;103(6):599-602. doi: 10.1080/00015458.2003.11679500.
10
Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.腹腔镜腹膜后淋巴结清扫术:在临床I期非精原细胞瘤性睾丸癌的治疗中仍有作用吗?欧洲视角。
Eur Urol. 2008 Nov;54(5):1004-15. doi: 10.1016/j.eururo.2008.08.022. Epub 2008 Aug 13.

引用本文的文献

1
Metachronous bilateral testicular germ cell tumors with different histopathology: A case report.异时性双侧睾丸生殖细胞肿瘤伴不同组织病理学表现:一例报告
Urol Case Rep. 2023 Nov 9;51:102612. doi: 10.1016/j.eucr.2023.102612. eCollection 2023 Nov.
2
Robotic retroperitoneal lymph node dissection for paratesticular rhabdomyosarcoma in adolescents: a case series.青少年腹膜后生殖嵴横纹肌肉瘤的机器人辅助 Retroperitoneal lymph node dissection:病例系列。
J Robot Surg. 2023 Dec;17(6):3045-3048. doi: 10.1007/s11701-023-01735-3. Epub 2023 Nov 16.
3
Associations of serum levels of microRNA-371a-3p (M371) with risk factors for progression in nonseminomatous testicular germ cell tumours clinical stage 1.
血清 microRNA-371a-3p(M371)水平与临床分期 1 期非精原细胞瘤性生殖细胞肿瘤进展风险因素的相关性。
World J Urol. 2022 Feb;40(2):317-326. doi: 10.1007/s00345-021-03876-2. Epub 2021 Nov 14.
4
Major complications of post-chemotherapy retroperitoneal lymph node dissection in a contemporary cohort of patients with testicular cancer and a review of the literature.当代睾丸癌患者化疗后腹膜后淋巴结清扫术的主要并发症及文献综述
World J Surg Oncol. 2020 Sep 24;18(1):253. doi: 10.1186/s12957-020-02032-1.
5
Is there still a place for retroperitoneal lymph node dissection in clinical stage 1 nonseminomatous testicular germ-cell tumours? A retrospective clinical study.对于临床分期为1期的非精原细胞性睾丸生殖细胞肿瘤,腹膜后淋巴结清扫术在临床中仍有存在的价值吗?一项回顾性临床研究。
BMC Urol. 2018 Oct 26;18(1):95. doi: 10.1186/s12894-018-0412-x.
6
Testicular cancer.睾丸癌。
Nat Rev Dis Primers. 2018 Oct 5;4(1):29. doi: 10.1038/s41572-018-0029-0.
7
Critical evaluation of modified templates and current trends in retroperitoneal lymph node dissection.改良模板的批判性评价及腹膜后淋巴结清扫术的当前趋势。
Curr Urol Rep. 2013 Oct;14(5):511-7. doi: 10.1007/s11934-013-0366-1.
8
Fertility preservation in the male with cancer.男性癌症患者的生育力保存。
Curr Urol Rep. 2013 Aug;14(4):315-26. doi: 10.1007/s11934-013-0345-6.
9
Sperm banking and the cancer patient.精子库与癌症患者。
Ther Adv Urol. 2010 Feb;2(1):19-34. doi: 10.1177/1756287210368279.
10
[Lymphadenectomy for testicular cancer. Diagnostic and prognostic significance as well as therapeutic benefit].[睾丸癌的淋巴结清扫术。诊断和预后意义以及治疗益处]
Urologe A. 2005 Jun;44(6):652-6. doi: 10.1007/s00120-005-0824-6.